KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $192.7 million.

  • Staar Surgical's Cash & Current Investments fell 1834.99% to $192.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $192.7 million, marking a year-over-year decrease of 1834.99%. This contributed to the annual value of $230.5 million for FY2024, which is 442.54% up from last year.
  • As of Q3 2025, Staar Surgical's Cash & Current Investments stood at $192.7 million, which was down 1834.99% from $189.9 million recorded in Q2 2025.
  • Staar Surgical's 5-year Cash & Current Investments high stood at $245.1 million for Q1 2024, and its period low was $152.5 million during Q1 2021.
  • Moreover, its 5-year median value for Cash & Current Investments was $201.1 million (2021), whereas its average is $203.0 million.
  • In the last 5 years, Staar Surgical's Cash & Current Investments skyrocketed by 5291.34% in 2021 and then tumbled by 1926.74% in 2025.
  • Over the past 5 years, Staar Surgical's Cash & Current Investments (Quarter) stood at $199.7 million in 2021, then increased by 5.98% to $211.6 million in 2022, then grew by 4.29% to $220.7 million in 2023, then rose by 4.43% to $230.5 million in 2024, then fell by 16.41% to $192.7 million in 2025.
  • Its Cash & Current Investments stands at $192.7 million for Q3 2025, versus $189.9 million for Q2 2025 and $222.8 million for Q1 2025.